Haemonetics Corporation Cash Flow-to-Debt Ratio
Haemonetics Corporation cash flow-to-debt ratio. Haemonetics Corporation (HAE) has a Cash Flow-to-Debt Ratio of 0.04x as of March 2026, meaning its operating cash flow of $70.94 Million could theoretically repay 0% of its total liabilities ($1.60 Billion) in one year. Check Haemonetics Corporation (HAE) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Haemonetics Corporation (1992–2026)
Cash flow-to-debt ratio of Haemonetics Corporation from 1992 to 2026. Historical debt coverage capacity for Haemonetics Corporation across 35 annual periods. Check HAE operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Haemonetics Corporation Cash Flow-to-Debt Ratio by Year (1992–2026)
Haemonetics Corporation cash flow-to-debt ratio by year from 1992 to 2026. Year-by-year debt coverage analysis for Haemonetics Corporation. For the full cash flow conversion analysis, see how efficiently does Haemonetics Corporation generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.20x | $293.22 Million | $1.50 Billion | ▲ +75.1% |
| 2025 | 0.11x | $181.72 Million | $1.63 Billion | ▼ -24.2% |
| 2024 | 0.15x | $181.75 Million | $1.24 Billion | ▼ -39.8% |
| 2023 | 0.24x | $273.06 Million | $1.12 Billion | ▲ +57.6% |
| 2022 | 0.16x | $172.26 Million | $1.11 Billion | ▲ +55.2% |
| 2021 | 0.10x | $108.81 Million | $1.09 Billion | ▼ -57.0% |
| 2020 | 0.23x | $158.22 Million | $680.00 Million | ▼ -11.3% |
| 2019 | 0.26x | $159.28 Million | $606.90 Million | ▼ -42.2% |
| 2018 | 0.45x | $220.35 Million | $484.91 Million | ▲ +42.0% |
| 2017 | 0.32x | $159.74 Million | $499.10 Million | ▲ +56.8% |
| 2016 | 0.20x | $121.86 Million | $597.13 Million | ▲ +5.4% |
| 2015 | 0.19x | $127.18 Million | $657.00 Million | ▼ -5.5% |
| 2014 | 0.20x | $139.52 Million | $681.23 Million | ▲ +66.8% |
| 2013 | 0.12x | $85.07 Million | $692.69 Million | ▼ -81.3% |
| 2012 | 0.66x | $115.32 Million | $175.56 Million | ▼ -21.7% |
| 2011 | 0.84x | $123.45 Million | $147.13 Million | ▲ +3.4% |
| 2010 | 0.81x | $130.67 Million | $161.02 Million | ▼ -23.4% |
| 2009 | 1.06x | $116.36 Million | $109.81 Million | ▲ +56.6% |
| 2008 | 0.68x | $77.67 Million | $114.76 Million | ▼ -24.6% |
| 2007 | 0.90x | $83.56 Million | $93.09 Million | ▲ +10.0% |
| 2006 | 0.82x | $85.62 Million | $104.89 Million | ▲ +29.1% |
| 2005 | 0.63x | $71.21 Million | $112.62 Million | ▲ +8.2% |
| 2004 | 0.58x | $74.61 Million | $127.64 Million | ▲ +82.0% |
| 2003 | 0.32x | $43.67 Million | $135.97 Million | ▲ +27.6% |
| 2002 | 0.25x | $32.24 Million | $128.10 Million | ▼ -46.5% |
| 2001 | 0.47x | $61.01 Million | $129.80 Million | ▲ +25.4% |
| 2000 | 0.37x | $53.47 Million | $142.67 Million | ▲ +49.6% |
| 1999 | 0.25x | $33.70 Million | $134.50 Million | ▲ +74.4% |
| 1998 | 0.14x | $20.40 Million | $142.00 Million | ▼ -47.2% |
| 1997 | 0.27x | $26.70 Million | $98.20 Million | ▼ -64.9% |
| 1996 | 0.77x | $54.80 Million | $70.80 Million | ▲ +333.1% |
| 1995 | 0.18x | $15.60 Million | $87.30 Million | ▼ -53.7% |
| 1994 | 0.39x | $27.00 Million | $69.90 Million | ▼ -42.3% |
| 1993 | 0.67x | $35.90 Million | $53.60 Million | ▲ +93.1% |
| 1992 | 0.35x | $18.80 Million | $54.20 Million | — |